SCHEMBL3769833

SCHEMBL3769833

Fc1ccc(F)c(C(=Cc2cccc(Cl)c2)CCl)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 2/20 0.40
FBP1 P09467 1/20 0.39
PTGS1 P23219 1/20 0.39
PPARG P37231 1/20 0.39
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
HDAC8 Q9BY41 1/20 0.37
CHRM5 P08912 1/20 0.37
FADS1 O60427 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NFE2L2 Q16236 1/20 0.36
CHAT P28329 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
POLB P06746 1/20 0.35
PKM P14618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3769829 1.00 MDM2 (0.40) MDM2FBP1PTGS1PPARGCES2
SCHEMBL3768883 0.90 PTGS1 (0.41) MDM2FBP1PTGS1PPARGCES2
SCHEMBL3768878 0.90 PTGS1 (0.41) MDM2FBP1PTGS1PPARGCES2
SCHEMBL3663676 0.84 FBP1 (0.40) FBP1PTGS1CHRM5CYP1A2CYP2C9
SCHEMBL3772088 0.84 FBP1 (0.40) FBP1PTGS1CHRM5CYP1A2CYP2C9
SCHEMBL3767511 0.84 ALDH1A1 (0.41) MDM2CES2CES1CYP1A2CYP2C9
SCHEMBL3767517 0.84 ALDH1A1 (0.41) MDM2CES2CES1CYP1A2CYP2C9
SCHEMBL2918837 0.81 PTGS1 (0.49) FBP1PTGS1CES2CES1CHRM5
SCHEMBL3766762 0.81 PTGS1 (0.49) FBP1PTGS1CES2CES1CHRM5
SCHEMBL3762718 0.77 MDM2 (0.40) MDM2CES2CES1HDAC8KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100317515-A1 Azolylmethyloxiranes, use Thereof and Agents Containing the Same BASF SE (DE) 2010-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317515-A1 Azolylmethyloxiranes, use Thereof and Agents Containing the Same XDH, NOX5, TET1 MDM2 3459/4885FBP1 855/4885PTGS1 259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.